Revenue

New data reveals Mesoblast's cell therapy Ryoncil dramatically boosts survival in GvHD patients when used early, paving the way for a major adult trial.

Gabelli Multimedia Trust maintains its high-yield distribution after a blockbuster 2025, but what does its 21% 'cash on cash' payout really mean for investors?

A court affirmed Avon must pay $51M for a woman's death from asbestos-laced talc, part of a wider legal storm engulfing the cosmetics industry.

Proem Acquisition Corp I launches a $130M IPO, led by tech IPO guru Imran Khan. But can it succeed in a revived, yet risk-laden, SPAC landscape?

The satellite firm unveils a complex debt shuffle and $1B capital raise, fueling its network vision while sending its stock tumbling on dilution fears.

As a Fed study confirms the 'harvest now, decrypt later' threat is active, Dr. Joseph Kearney joins QRL to spearhead a quantum-safe future for blockchain.

As Caroline Dorsa retires, Biogen elects Dr. Maria Freire as its new chair, a strategic move placing deep scientific expertise at the helm for a critical period.

Dating apps are out, and home cooking is in. A new campaign from Knorr taps into Gen Z's search for authenticity, turning kitchens into the new frontier for romance.

Data engine Cribl surpasses $300M in recurring revenue, positioning its open architecture as the essential plumbing for enterprises drowning in AI data.

Grid Dynamics' new 'Preferred Vendor' status with a top cloud provider validates its role in solving the complex engineering challenges of enterprise AI.

The specialty food giant adds Suntory Global Spirits CEO Greg Hughes to its board, a strategic move to leverage premium brand and operational expertise.

The health tech firm posts strong revenue and positive EBITDA, but SEC filings and a falling stock price reveal a more complex and challenging road ahead.

Tired of reactive IRS notices? A new AI platform offers continuous monitoring to help businesses and tax pros stay ahead of compliance risks.

A new partnership with fintech firm april aims to ease the tax burden for consumers navigating debt settlement, setting a new standard for the industry.

As BJ’s prepares to report Q4 results, investors are watching if a pizza relaunch and new efficiencies can overcome industry-wide cost pressures.

With a strong cash position, Arcus Biosciences heads into a pivotal year as investors await critical data on its promising cancer and autoimmune pipeline.

NXP expands its use of Arteris's specialized IP, a strategic move to accelerate its dominance in the competitive automotive and industrial edge AI markets.

With the hire of elite dealmaker George F. Schoen, the building materials giant is signaling a new era of aggressive M&A and strategic consolidation.

The nation's largest private bank is expanding its Oklahoma City campus, acquiring a former energy building in a move that signals local faith and national ambition.

The waste giant affirmed its quarterly dividend, backed by robust earnings and a positive outlook, highlighting sector stability and long-term value for investors.